Home » Infinity Pharma’s Cancer Drug Fails Mid-Stage Trial Goals
Infinity Pharma’s Cancer Drug Fails Mid-Stage Trial Goals
Infinity Pharmaceuticals’ cancer drug retaspimycin HCl failed to meet its goal of prolonging survival in patients with a type of lung cancer closely linked to smoking.
Reuters
Reuters
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May